|
115
|
350
|
1smhA |
Protein kinase a variant complex with completely ordered n-terminal helix |
|
103
|
350
|
1sykA |
Crystal structure of e230q mutant of camp-dependent protein kinase reveals unexpected apoenzyme conformation |
|
67
|
263
|
1snuA |
Crystal structure of the unphosphorylated interleukin-2 tyrosine kinase catalytic domain |
|
95
|
336
|
1stcE |
Camp-dependent protein kinase, alpha-catalytic subunit in complex with staurosporine |
|
105
|
331
|
1t45A |
Structural basis for the autoinhibition and sti-571 inhibition of c-kit tyrosine kinase |
|
106
|
337
|
1svhA |
Crystal structure of protein kinase a in complex with azepane derivative 8 |
|
109
|
344
|
1sveA |
Crystal structure of protein kinase a in complex with azepane derivative 1 |
|
54
|
263
|
1snxA |
Crystal structure of apo interleukin-2 tyrosine kinase catalytic domain |
|
73
|
322
|
1s9jA |
X-ray structure of the human mitogen-activated protein kinase kinase 1 (mek1) in a complex with ligand and mgatp |
|
77
|
334
|
1s9iA |
X-ray structure of the human mitogen-activated protein kinase kinase 2 (mek2)in a complex with ligand and mgatp |
|
81
|
301
|
1rw8A |
Crystal structure of tgf-beta receptor i kinase with atp site inhibitor |
|
73
|
263
|
1sm2A |
Crystal structure of the phosphorylated interleukin-2 tyrosine kinase catalytic domain |
|
97
|
338
|
1rekA |
Crystal structure of camp-dependent protein kinase complexed with balanol analog 8 |
|
92
|
311
|
1r1wA |
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met |
|
105
|
348
|
1r39A |
The structure of p38alpha |
|
97
|
311
|
1r0pA |
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with the microbial alkaloid k-252a |
|
109
|
350
|
1rdqE |
Hydrolysis of atp in the crystal of y204a mutant of camp-dependent protein kinase |
|
106
|
349
|
1r0eA |
Glycogen synthase kinase-3 beta in complex with 3-indolyl-4-arylmaleimide inhibitor |
|
104
|
335
|
1rejA |
Crystal structure of camp-dependent protein kinase complexed with balanol analog 1 |
|
108
|
349
|
1r3cA |
The structure of p38alpha c162s mutant |
|
88
|
297
|
1rqqA |
Crystal structure of the insulin receptor kinase in complex with the sh2 domain of aps |
|
97
|
339
|
1re8A |
Crystal structure of camp-dependent protein kinase complexed with balanol analog 2 |
|
95
|
325
|
1rjbA |
Crystal structure of flt3 |
|
72
|
298
|
1r78A |
Cdk2 complex with a 4-alkynyl oxindole inhibitor |
|
114
|
363
|
1q99A |
Crystal structure of the saccharomyces cerevisiae sr protein kinsae, sky1p, complexed with the non-hydrolyzable atp analogue, amp-pnp |
|
80
|
266
|
1qpjA |
Crystal structure of the lymphocyte-specific kinase lck in complex with staurosporine. |
|
88
|
281
|
1ql6A |
The catalytic mechanism of phosphorylase kinase probed by mutational studies |
|
90
|
271
|
1qpcA |
Structural analysis of the lymphocyte-specific kinase lck in complex with non-selective and src family selective kinase inhibitors |
|
110
|
340
|
1q8tA |
The catalytic subunit of camp-dependent protein kinase (pka) in complex with rho-kinase inhibitor y-27632 |
|
87
|
271
|
1qpdA |
Structural analysis of the lymphocyte-specific kinase lck in complex with non-selective and src family selective kinase inhibitors |
|
112
|
362
|
1q97A |
The structure of the saccharomyces cerevisiae sr protein kinase, sky1p, with bound atp |
|
88
|
271
|
1qpeA |
Structural analysis of the lymphocyte-specific kinase lck in complex with non-selective and src family selective kinase inhibitors |
|
121
|
450
|
1qcfA |
Crystal structure of hck in complex with a src family-selective tyrosine kinase inhibitor |
|
85
|
297
|
1qmzA |
Phosphorylated cdk2-cyclyin a-substrate peptide complex |
|
100
|
356
|
1pmuA |
The crystal structure of jnk3 in complex with a phenantroline inhibitor |
|
95
|
352
|
1q3wA |
Gsk-3 beta complexed with alsterpaullone |
|
82
|
298
|
1pxmA |
Human cyclin dependent kinase 2 complexed with the inhibitor 3-[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-ylamino]-phenol |
|
113
|
338
|
1q62A |
Pka double mutant model of pkb |
|
76
|
298
|
1pxnA |
Human cyclin dependent kinase 2 complexed with the inhibitor 4-[4-(4-methyl-2-methylamino-thiazol-5-yl)-pyrimidin-2-ylamino]-phenol |
|
99
|
356
|
1pmvA |
The structure of jnk3 in complex with a dihydroanthrapyrazole inhibitor |
|
81
|
298
|
1pxlA |
Human cyclin dependent kinase 2 complexed with the inhibitor [4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-(4-trifluoromethyl-phenyl)-amine |
|
79
|
298
|
1pw2A |
Apo structure of human cyclin-dependent kinase 2 |
|
97
|
350
|
1q5kA |
Crystal structure of glycogen synthase kinase 3 in complexed with inhibitor |
|
99
|
352
|
1pyxA |
Gsk-3 beta complexed with amp-pnp |
|
82
|
298
|
1pxoA |
Human cyclin dependent kinase 2 complexed with the inhibitor [4-(2-amino-4-methyl-thiazol-5-yl)-pyrimidin-2-yl]-(3-nitro-phenyl)-amine |
|
103
|
356
|
1pmnA |
Crystal structure of jnk3 in complex with an imidazole-pyrimidine inhibitor |
|
99
|
352
|
1q4lA |
Gsk-3 beta complexed with inhibitor i-5 |
|
73
|
298
|
1pyeA |
Crystal structure of cdk2 with inhibitor |
|
78
|
298
|
1pxkA |
Human cyclin dependent kinase 2 complexed with the inhibitor n-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-n'-hydroxyiminoformamide |
|
83
|
297
|
1pkdA |
The crystal structure of ucn-01 in complex with phospho-cdk2/cyclin a |
